TauC3 Biologics
Phase 2A new approach to halting the spread of tau pathology and destruction of nerve cells in the brain
Founded
2018
Focus
AntibodiesBiologics
About
A new approach to halting the spread of tau pathology and destruction of nerve cells in the brain
Company Info
TypePrivate
Founded2018
LocationLondon, United Kingdom
StagePhase 2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile